Genetic Biomarkers Detection Service
At present, genetic biomarkers are mostly used in the screening and diagnosis researches of diseases, so the research of genetic biomarkers has great development potential in the field of molecular diagnostic research. As a leader in the field of biomarkers detection, Creative BioMart Biomarker has established a one-stop detection service platform for biomarkers, providing a variety of related research outsourcing services. Creative BioMart Biomarker uses its own technical team and first-class technology platform to provide customers with high-quality multiple biomarker detection services, including genetic biomarkers detection services.
Introduction
In addition to protein biomarkers, genetic biomarkers are also an important category of biomarkers. Genetic biomarkers generally refer to specific markers present in the patient's genes. The etiology of diseases is generally very complicated, and their occurrence is often the result of a combination of multiple factors. It belongs to a multi-step physiological process, which may involve genetic variation in the genome. Genes are sequences of chromosomal DNA required for the synthesis of functional proteins or functional RNA molecules, which include not only coding sequences but also adjacent nucleotide sequences. The DNA in the gene is transcribed to form mRNA, and then amino acids are formed to synthesize proteins through the translation process. The information in the gene is thus expressed as a specific protein, which participates in physiological activities and affects the physiological function of the human body. The information in the genes is hereditary and may lead to the generation of genetic traits and genetic diseases. In addition to genetic diseases, many diseases are related to defects or mutations in genes. This is because almost all cells, tissues, and organs in the body are regulated by gene expression. Therefore, genetic biomarkers can be used not only for the study of genetic diseases, but also for the study of other diseases, such as cancer. The detection and research of genetic biomarkers have great potential for development in disease prediction, screening, prognosis and risk assessment. With the development of biotechnology, the detection and analysis technology of genetic biomarkers has been further developed, making it possible to carry out efficient and high-throughput analysis.
Application
Genetic biomarkers detection service is applicable to the diagnosis and screening researches of various diseases, including genetic diseases, cancer, endometriosis, cardiovascular diseases, etc.
Our Services for Genetic Biomarkers Detection (including but not limited to the following):
Our Advantages
- Multiple detection technology platforms (DNA microarray, high-throughput sequencing, etc.)
- Ensure high specificity and sensitivity multiple biomarkers detection service
- Provide high-throughput analysis services
- Applicable to a large number of disease-related biomarkers
- Short turn-around time of detection service
- Competitive price in the market of biomarkers detection services
- Experienced technical team
Workflow of Multiple Biomarker Detection at Creative BioMart Biomarker
Creative BioMart Biomarker has always provided customers with high-quality genetic biomarkers detection service. Customers can discuss with our expert team according to specific research needs or research objects. We will work out the appropriate experimental program as soon as possible. Creative BioMart Biomarker has an experienced technical team and strictly control every process in the multiple biomarker detection to ensure the accuracy and repeatability of each test result. If you have any questions about our services, please feel free to contact us, Creative BioMart Biomarker is here to offer you professional and thoughtful service.
References:
- Coppedè, F.; et al. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer. World Journal of Gastroenterology. 2014, 20(4): 943–956.
- Jain, K. K. (2017) The handbook of biomarkers. (2nd ed). New York: Springer Nature.
